The international drug conventions were created to ensure the “health and welfare of mankind”, yet drug policies around the world continue to focus on criminal justice and repression rather than on health responses. Governments across the world should provide harm reduction and treatment interventions to reduce the harms associated with drug use, and ensure adequate access to essential medicines.
Mr. Marco Di Paolo, a multiple sclerosis sufferer from the town of Sulmona, went to court to have access to medical marijuana. The judge ruled that, under certain circumstances, the Local Health Authority is obliged to provide marijuana for medical purposes.
The Open Society Institute's International Harm Reduction Development Program (IHRD) developed Methadone Man and Buprenorphine Babe to help raise awareness about the glaring lack of access to these lifesaving drugs.
This workshop will teach basic techniques of preventing and recognising overdose and will train participants how to teach opiate users and their community to respond effectively with naloxone; it will examine best practices of integrating overdose response into the work of harm reduction and AIDS service organisations; and we will discuss how addressing this major cause of death can have an impact on increasing the effectiveness of HIV programming.
Compulsory centres for drug users are plagued with high relapse rates and high financial and human costs that burden the State, the overall community and drug users and their families alike. The approach creates a dangerous ‘revolving door’ for drug users, and is an obstacle to achieving Universal Access.
The Human Rights March and Rally on July 20 will be a historic event where thousands will join in solidarity with human rights defenders around the world. The March and Rally is an opportunity for all people whose human rights are affected by HIV to make their voice heard.
As the second major report in the series, the document provides a region-by-region update of key developments in harm reduction, as well as several issues key to the response to drug-related harms worldwide.
Despite good evidence for its effectiveness in HIV prevention, countries such as Russia remain resistant to harm reduction. This article shows the obstacles to and potential benefits of changing policy on opiate substitution treatment.